The title compound, C 15 H 14 N 4 O, crystallizes with two molecules in the asymmetric unit with similar conformations (r.m.s. overlay fit for the 20 non-H atoms = 0.175 Å ). In the first molecule, the dihedral angles between the planes of the central pyrazole ring and the pendant phenyl and pyrrole rings are 42.69 (8) and 51.88 (6) , respectively, with corresponding angles of 54.49 (7) and 49.61 (9) , respectively, in the second molecule. In the crystal, the two molecules, together with their inversion-symmetry counterparts, are linked into tetramers by O-HÁ Á ÁN hydrogen bonds. The tetramers form layers parallel to (211) through pairwise C-HÁ Á Á interactions.
Related literature
For use of pyrazoles in synthesis of polyfunctionally substituted heterocycles, see: Elnagdi et al. (1987) ; Quiroga et al. (2007 Quiroga et al. ( , 2008a ; Aly et al. (1994) . For pharmaceutical properties of pyrazole-containing compounds, see: Bazgir et al. Table 1 Hydrogen-bond geometry (Å , ) .
Cg is centroid of C1-C6 ring. Pyrazoles are interested class of heterocyclic compounds for chemists and pharmacists due to their diverse synthetic and biological applications. Pyrazoles are excellent precursors for the synthesis of condensed polyfunctionally substituted heterocycles (Elnagdi et al., 1987; Quiroga et al., 2007; Quiroga et al., 2008a,b; Aly et al., 1994) . Moreover, pyrazole containing compounds exhibit a broad spectrum of pharmaceutical properties such as anti-hyperglycemic and analgesic (Bazgir, et al., 2008 ), anti-parasitic (Dias et al., 1994 anti-microbial (El-Kashef et al., 2000) and anti-schistosomal activities (El-Emary et al., 2002) . Following our on-going study in the synthesis and characterization of new bio-active heterocyclic compounds, we report here the crystal structure determination of the title compound.
D-HÁ
There are two independent molecules of the title compound in the asymmetric unit which differ primarily in the orientation of the pendant phenyl and pyrrolyl rings. Thus the dihedral angles between these rings, respectively, and the central heterocyclic ring are 42.69 (8) and 51.88 (6)° in molecule 1 but 54.49 (7) and 49.61 (9)° in molecule 2. Molecules 1 at x, y, z and 1 -x, -1 -y, 2 -z and molecules 2 at x, -1 + y, z and 1 -x, -y, 2 -z are associated into a cyclic tetramer via O-H···N(2 or 6) hydrogen bonds (Table 1 and Fig. 2 ). These units form sheets approximately parallel to (100) (Fig. 2 ) in which the major inter-tetramer interaction within the sheet appears to be pairwise C-H···π (C11-H11···Cg: H···Cg = 3.45 Å, C-H···Cg = 170° (Cg is centroid of C1-C6 ring at 1 -x, -y, 2 -z).
S2. Experimental
A mixture of 760 mg (3 mmol) 3-methyl-1-phenyl-5-(1H-pyrrol-1-yl)-4,5-dihydro-1H-pyrazole-4-carbaldehyde and 208.5 mg (3 mmol) of hydroxylamine hydrochloride in 15 ml pyridine was heated under reflux for 3 h. After cooling, the reaction mixture was poured into cold water. The resulting solid product was filtered, washed with water, dried under vacuum and crystallized from dioxane to give colourless plates Yield 76%, m.p. 463-465 K. 
S3. Refinement

Figure 1
The asymmetric unit of the title compound with 50% probability ellipsoids. 
Figure 3
Elevation view of the layers of H-bonded tetramers.
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